カテゴリー： MarketsandMarkets, 世界, 医療/バイオ

骨セメント＆接着剤の世界市場予測（～2028）：骨セメント別、骨接着剤別、充填別、用途別、エンドユーザー別、地域別

◆英語タイトル：Bone Cement & Glue Market by Bone Cement (PMMA, Calcium Phosphate), Bone Glue (Natural, Synthetic), Loading (Antibiotic Loaded), Application (Arthroplasty, Kyphoplasty, Vertebroplasty), End User (Hospitals, ASCS, Clinics) & Region - Global Forecast to 2028
	◆商品コード：MD5927-23 ◆発行会社（リサーチ会社）：MarketsandMarkets ◆発行日：2023年8月1日 ◆ページ数：184 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後24時間以内） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧）	USD4,950 ⇒換算￥742,500	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥997,500	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥1,222,500	見積依頼/購入/質問フォーム

★MarketsandMarketsに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

"世界の骨セメント＆接着剤市場は、2023年の16億4400万米ドルから2028年には22億4800万米ドルに達すると予測され、予測期間中の年平均成長率は6.5%" この市場の成長の主な原動力は、骨折や手術の増加、戦略的提携やパートナーシップです。しかし、コストと手頃な価格に関する課題は、この市場の成長を脅かす可能性があります。

"膝関節全置換術は予測期間中に最も高い成長を遂げる"
人工関節置換術市場は、タイプに基づいて、膝関節全置換術、股関節全置換術、肩関節全置換術に区分されます。膝関節全置換術は予測期間中に最も高いCAGRで成長すると予測されています。変形性膝関節症の有病率の増加と高齢化により、世界中でTKA手術の件数が増加しており、これが骨接着剤とセメント市場を牽引しています。

"欧州は予測期間中に3番目に高いCAGRを記録すると推定"
本レポートでは、骨セメント＆接着剤市場を4つの主要地域セグメントに区分しています。北米、欧州、アジア太平洋、その他の地域です。欧州市場は予測期間中に3番目に高い成長率を記録すると予測されています。この市場の成長の主な原動力は、65歳以上の高齢者の割合が高く、高齢化が進んでいることです。高齢化により、変形性関節症や骨折などの整形外科疾患が発生しやすくなり、骨セメントや接着剤を使用した外科手術が必要になることが多いこと、整形外科疾患の有病率の高さ、整形外科手術件数の増加、医療分野における技術進歩などが挙げられます。

供給側の一次インテビューの内訳、企業タイプ別、役職別、地域別：
- 企業タイプ別：ティア1 (48%)、ティア2 (34%)、ティア3 (18%)
- 役職別：Cレベル(33%)、ディレクターレベル(40%)、その他(27%)
- 地域別：北米 (36%)、ヨーロッパ (28%)、アジア太平洋 (20%)、その他の地域 (16%)

レポート掲載企業一覧
Stryker (US)
Zimmer Biomet (US)
DePuy Synthes (a subsidiary of Johnson & Johnson - US)
Smith+Nephew.(UK)
Arthrex, Inc. (US)
Enovis (US)
Globus Medical (US)
Exactech, Inc.(US)
Heraeus Holding (Germany)
Artivion, Inc (US)
Cardinal Health. (US)
Teknimed (France)
Medtronic (Ireland)
Tecres S.p.A.(Italy)
Bioceramed, S.A. (Portugal)
Evolutis (France)
Normmed Medical (Turkey)
LINACOL Medical (Turkey)
BPB MEDICA (Italy)
 IZI Medical (US)
Aditus Medical. (Germany)
OSARTIS GmbH (Germany)
LD Davis (US)
Milligan & Higgins (US)
VHERN srl (US)

調査範囲
この調査レポートは、骨セメント＆接着剤市場を製品別、地域別に調査しています。また、市場成長に影響を与える要因（促進要因、機会、課題、阻害要因など）を分析しています。利害関係者向けに市場の機会と課題を評価し、市場リーダー向けに競争状況の詳細を提供します。また、微小市場についても、その成長動向、展望、骨セメント＆接着剤市場全体への貢献などを調査しています。レポートでは、主要5地域に関して市場セグメントの収益を予測しています。

レポートを購入する理由
本レポートは、以下のポイントに関する洞察を提供します：
-市場浸透：骨セメント＆接着剤市場の上位25社が提供するバイオ除染製品に関する包括的な情報。骨セメント＆接着剤市場をタイプ別、地域別に分析
-市場促進要因：特定の市場の成長とパフォーマンスを刺激し、影響を与える要因や条件に関する包括的な情報
-市場の発展：有利な新興市場に関する包括的情報。主要地域にわたる様々な固定装置市場を分析
-市場の多様化：骨セメント＆接着剤市場における未開拓の地域、最近の開発、投資に関する詳細な情報
-競合評価：骨セメント＆接着剤市場における主要企業の市場シェアと戦略を詳細に評価

1. はじめに
2. 調査方法
3. エグゼクティブサマリー
4. プレミアムインサイト
5. 市場概要
6. 骨セメント＆接着剤市場：タイプ別
7. 骨セメント＆接着剤市場：用途別
8. 骨セメント＆接着剤市場：エンドユーザー別
9. 骨セメント＆接着剤市場：地域別
10. 競争状況
11. 企業情報
12. 付録

❖ レポートの目次 ❖

1 INTRODUCTION 23
1.1 STUDY OBJECTIVES 23
1.2 MARKET DEFINITION 23
1.2.1 INCLUSIONS AND EXCLUSIONS 23
1.3 MARKET SCOPE 24
1.3.1 MARKETS COVERED 24
1.3.2 REGIONS COVERED 24
1.3.3 YEARS CONSIDERED 25
1.3.4 CURRENCY CONSIDERED 25
1.4 LIMITATIONS 25
1.5 STAKEHOLDERS 26
1.6 RECESSION IMPACT 26
2 RESEARCH METHODOLOGY 27
FIGURE 1 RESEARCH DESIGN 27
2.1 RESEARCH DATA 28
2.1.1 SECONDARY DATA 28
2.1.1.1 Key data from secondary sources 28
2.1.2 PRIMARY DATA 29
FIGURE 2 PRIMARY SOURCES 29
2.1.2.1 Breakdown of primary interviews 30
2.1.2.2 Key data from primary sources 31
2.2 MARKET SIZE ESTIMATION 32
FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 32
FIGURE 4 BOTTOM-UP APPROACH: PROCEDURE-BASED ANALYSIS 33
2.2.1 GROWTH FORECAST 33
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 34
FIGURE 6 TOP-DOWN APPROACH 34
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 35
FIGURE 7 DATA TRIANGULATION METHODOLOGY 35
2.4 ASSUMPTIONS 36
2.5 RECESSION IMPACT ANALYSIS 36
3 EXECUTIVE SUMMARY 37
FIGURE 8 BONE CEMENT & GLUE MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 37
FIGURE 9 BONE CEMENT & GLUE MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 38
FIGURE 10 BONE CEMENT & GLUE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 38
FIGURE 11 BONE CEMENT & GLUE MARKET, BY REGION, 2023 VS. 2028 (USD MILLION) 39
4 PREMIUM INSIGHTS 40
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN BONE CEMENT & GLUE MARKET 40
FIGURE 12 GROWING GERIATRIC POPULATION TO DRIVE MARKET 40
4.2 BONE CEMENT MARKET, BY TYPE 41
FIGURE 13 PMMA CEMENT TO REGISTER HIGHER GROWTH OVER FORECAST PERIOD 41
4.3 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY TYPE AND COUNTRY 42
FIGURE 14 US ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA IN 2022 42
4.4 BONE CEMENT & GLUE MARKET, BY COUNTRY 43
FIGURE 15 INDIA AND CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD 43
5 MARKET OVERVIEW 44
5.1 INTRODUCTION 44
5.2 MARKET DYNAMICS 44
FIGURE 16 BONE CEMENT & GLUE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 44
5.2.1 DRIVERS 45
5.2.1.1 Growing incidence of sports injuries 45
5.2.1.2 Rapid growth in geriatric population 45
TABLE 1 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 VS. 2050 (MILLION) 46
5.2.1.3 Developments in regenerative medicine 47
5.2.1.4 Growing number of road traffic accidents and other factors increasing surgery volumes 48
5.2.1.5 Technological advancements 48
5.2.2 RESTRAINTS 49
5.2.2.1 High costs and extensive clinical data requirements for launching new products 49
5.2.2.2 Alternatives to bone cement and glue 50
5.2.3 OPPORTUNITIES 51
5.2.3.1 Growth opportunities in emerging economies 51
5.2.3.2 Rising awareness and demand for minimally invasive procedures 51
5.2.4 CHALLENGES 52
5.2.4.1 Development of novel biomaterials with high mechanical properties and adhesion strength 52
5.2.4.2 Product-related complications 52
5.2.4.3 Unfavorable reimbursement scenario 53
6 BONE CEMENT & GLUE MARKET, BY TYPE 55
6.1 INTRODUCTION 56
TABLE 2 BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 56
6.2 BONE CEMENT 56
TABLE 3 CONSTITUENTS OF BONE CEMENT 57
TABLE 4 BONE CEMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 57
6.2.1 BONE CEMENT MARKET, BY TYPE 57
TABLE 5 BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 58
6.2.1.1 PMMA cement 58
6.2.1.1.1 Wide usage and properties of PMMA to drive market 58
TABLE 6 PMMA CEMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 58
6.2.1.2 Calcium phosphate cement 59
6.2.1.2.1 High biocompatibility and radiopacity to drive adoption 59
TABLE 7 CPC MARKET, BY REGION, 2021–2028 (USD MILLION) 59
6.2.1.3 Glass polyalkenoate cement 59
6.2.1.3.1 Wide applications in dentistry to drive market 59
TABLE 8 GPC MARKET, BY REGION, 2021–2028 (USD MILLION) 60
6.2.2 BONE CEMENT MARKET, BY LOADING 60
TABLE 9 BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 60
6.2.2.1 Antibiotic-loaded bone cement 61
6.2.2.1.1 High risk of developing deep infections during surgeries to support adoption 61
TABLE 10 ANTIBIOTIC-LOADED BONE CEMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 61
6.2.2.2 Non-antibiotic-loaded bone cement 61
6.2.2.2.1 Low cost and less-stringent regulations to support usage 61
TABLE 11 NON-ANTIBIOTIC-LOADED BONE CEMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 62
6.3 BONE GLUE 62
TABLE 12 BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 63
TABLE 13 BONE GLUE MARKET, BY REGION, 2021–2028 (USD MILLION) 63
6.3.1 NATURAL BONE GLUE 63
6.3.1.1 High biocompatibility to support greater adoption 63
TABLE 14 NATURAL BONE GLUE MARKET, BY REGION, 2021–2028 (USD MILLION) 64
6.3.2 SYNTHETIC BONE GLUE 64
6.3.2.1 Emerging medical applications indicate high potential of synthetic glue 64
TABLE 15 SYNTHETIC BONE GLUE MARKET, BY REGION, 2021–2028 (USD MILLION) 64
7 BONE CEMENT & GLUE MARKET, BY APPLICATION 65
7.1 INTRODUCTION 66
TABLE 16 BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 66
7.2 ARTHROPLASTY 66
TABLE 17 BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY REGION, 2021–2028 (USD MILLION) 67
TABLE 18 BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 67
7.2.1 TOTAL KNEE ARTHROPLASTY 67
7.2.1.1 TKA to hold largest arthroplasty market share 67
TABLE 19 BONE CEMENT & GLUE MARKET FOR TOTAL KNEE ARTHROPLASTY, BY REGION, 2021–2028 (USD MILLION) 68
7.2.2 TOTAL HIP ARTHROPLASTY 68
7.2.2.1 Growing geriatric population to boost procedural volumes 68
TABLE 20 BONE CEMENT & GLUE MARKET FOR TOTAL HIP ARTHROPLASTY, BY REGION, 2021–2028 (USD MILLION) 69
7.2.3 TOTAL SHOULDER ARTHROPLASTY 69
7.2.3.1 Rising sports injury incidence to drive market 69
TABLE 21 BONE CEMENT & GLUE MARKET FOR TOTAL SHOULDER ARTHROPLASTY, BY REGION, 2021–2028 (USD MILLION) 70
7.3 KYPHOPLASTY 70
7.3.1 INCREASING INCIDENCE OF OSTEOPOROSIS TO DRIVE MARKET 70
TABLE 22 TOP TEN COUNTRIES IN KYPHOPLASTY RESEARCH 71
TABLE 23 BONE CEMENT & GLUE MARKET FOR KYPHOPLASTY, BY REGION, 2021–2028 (USD MILLION) 71
7.4 VERTEBROPLASTY 71
7.4.1 RISING INCIDENCE OF VERTEBRAL COMPRESSION FRACTURES TO SUPPORT MARKET GROWTH 71
TABLE 24 BONE CEMENT & GLUE MARKET FOR VERTEBROPLASTY, BY REGION, 2021–2028 (USD MILLION) 72
7.5 OTHER APPLICATIONS 72
TABLE 25 BONE CEMENT & GLUE MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 73
8 BONE CEMENT & GLUE MARKET, BY END USER 74
8.1 INTRODUCTION 75
TABLE 26 BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 75
8.2 HOSPITALS & ASCS 75
8.2.1 HOSPITALS & ASCS TO DOMINATE END-USER MARKET 75
TABLE 27 BONE CEMENT & GLUE MARKET FOR HOSPITALS & ASCS, BY REGION, 2021–2028 (USD MILLION) 76
8.3 CLINICS & PHYSICIAN OFFICES 76
8.3.1 RISING PREFERENCE FOR CLINICS AND COST-SAVING POTENTIAL TO DRIVE MARKET 76
TABLE 28 BONE CEMENT & GLUE MARKET FOR CLINICS & PHYSICIAN OFFICES, BY REGION, 2021–2028 (USD MILLION) 77
9 BONE CEMENT & GLUE MARKET, BY REGION 78
9.1 INTRODUCTION 79
TABLE 29 BONE CEMENT & GLUE MARKET, BY REGION, 2021–2028 (USD MILLION) 79
9.2 NORTH AMERICA 80
9.2.1 NORTH AMERICA: RECESSION IMPACT 80
FIGURE 17 NORTH AMERICA: BONE CEMENT & GLUE MARKET SNAPSHOT 81
TABLE 30 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 31 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 82
TABLE 32 NORTH AMERICA: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 82
TABLE 33 NORTH AMERICA: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 83
TABLE 34 NORTH AMERICA: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 83
TABLE 35 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 83
TABLE 36 NORTH AMERICA: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 84
TABLE 37 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 84
9.2.2 US 84
9.2.2.1 Growing geriatric population and high prevalence of sports injuries to drive market 84
FIGURE 18 TOTAL ESTIMATED INJURIES BY SPORTS ACTIVITY IN 2021 85
TABLE 38 US: KEY MACROINDICATORS 86
TABLE 39 US: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 86
TABLE 40 US: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 86
TABLE 41 US: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 87
TABLE 42 US: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 87
TABLE 43 US: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 87
TABLE 44 US: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 88
TABLE 45 US: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 88
9.2.3 CANADA 89
9.2.3.1 Availability of government funding and growth in geriatric population to drive market 89
TABLE 46 FUNDS FOR SPORTS ORGANIZATIONS, 2021/2022 (USD THOUSAND) 89
TABLE 47 CANADA: KEY MACROINDICATORS 89
TABLE 48 CANADA: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 90
TABLE 49 CANADA: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 90
TABLE 50 CANADA: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 90
TABLE 51 CANADA: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 91
TABLE 52 CANADA: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 91
TABLE 53 CANADA: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 91
TABLE 54 CANADA: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 92
9.3 EUROPE 92
TABLE 55 EUROPE: BURDEN OF OSTEOPOROSIS (2021) 92
9.3.1 EUROPE: RECESSION IMPACT 93
TABLE 56 EUROPE: BONE CEMENT & GLUE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 57 EUROPE: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 93
TABLE 58 EUROPE: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 94
TABLE 59 EUROPE: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 94
TABLE 60 EUROPE: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 94
TABLE 61 EUROPE: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 95
TABLE 62 EUROPE: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 95
TABLE 63 EUROPE: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 95
9.3.2 FRANCE 96
9.3.2.1 Rising government support to drive demand 96
TABLE 64 FRANCE: KEY MACROINDICATORS 96
TABLE 65 FRANCE: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 96
TABLE 66 FRANCE: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 97
TABLE 67 FRANCE: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 97
TABLE 68 FRANCE: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 97
TABLE 69 FRANCE: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 98
TABLE 70 FRANCE: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 98
TABLE 71 FRANCE: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 98
9.3.3 GERMANY 99
9.3.3.1 Robust healthcare spending and advanced healthcare system to favor market growth 99
TABLE 72 GERMANY: KEY MACROINDICATORS 99
TABLE 73 GERMANY: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 100
TABLE 74 GERMANY: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 100
TABLE 75 GERMANY: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 100
TABLE 76 GERMANY: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 101
TABLE 77 GERMANY: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 101
TABLE 78 GERMANY: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 101
TABLE 79 GERMANY: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 102
9.3.4 UK 102
9.3.4.1 Presence of strong healthcare infrastructure and high burden of orthopedic cases 102
TABLE 80 UK: KEY MACROINDICATORS 103
TABLE 81 UK: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 103
TABLE 82 UK: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 103
TABLE 83 UK: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 104
TABLE 84 UK: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 104
TABLE 85 UK: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 104
TABLE 86 UK: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 105
TABLE 87 UK: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 105
9.3.5 REST OF EUROPE 105
TABLE 88 REST OF EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2021 (% OF GDP) 106
TABLE 89 REST OF EUROPE: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 106
TABLE 90 REST OF EUROPE: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 107
TABLE 91 REST OF EUROPE: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 107
TABLE 92 REST OF EUROPE: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 107
TABLE 93 REST OF EUROPE: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 108
TABLE 94 REST OF EUROPE: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 108
TABLE 95 REST OF EUROPE: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 109
9.4 ASIA PACIFIC 109
9.4.1 ASIA PACIFIC: RECESSION IMPACT 109
FIGURE 19 ASIA PACIFIC: BONE CEMENT & GLUE MARKET SNAPSHOT 110
TABLE 96 ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 111
TABLE 97 ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 111
TABLE 98 ASIA PACIFIC: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 111
TABLE 99 ASIA PACIFIC: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 112
TABLE 100 ASIA PACIFIC: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 112
TABLE 101 ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 112
TABLE 102 ASIA PACIFIC: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 113
TABLE 103 ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 113
9.4.2 CHINA 113
9.4.2.1 China to hold largest market share in APAC 113
TABLE 104 CHINA: KEY MACROINDICATORS 114
TABLE 105 INCIDENCE OF OSTEOPOROTIC FRACTURES IN CHINA, 2015–2035 114
TABLE 106 CHINA: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 114
TABLE 107 CHINA: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 115
TABLE 108 CHINA: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 115
TABLE 109 CHINA: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 115
TABLE 110 CHINA: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 116
TABLE 111 CHINA: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 116
TABLE 112 CHINA: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 116
9.4.3 INDIA 117
9.4.3.1 Rising medical tourism, improving healthcare infrastructure, and growing population to drive market 117
TABLE 113 INDIA: KEY MACROINDICATORS 117
TABLE 114 INDIA: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 117
TABLE 115 INDIA: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 118
TABLE 116 INDIA: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 118
TABLE 117 INDIA: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 118
TABLE 118 INDIA: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 119
TABLE 119 INDIA: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 119
TABLE 120 INDIA: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 119
9.4.4 JAPAN 120
9.4.4.1 Large aging population and favorable government initiatives to drive market 120
TABLE 121 JAPAN: KEY MACROINDICATORS 120
TABLE 122 JAPAN: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 120
TABLE 123 JAPAN: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 121
TABLE 124 JAPAN: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 121
TABLE 125 JAPAN: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 121
TABLE 126 JAPAN: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 122
TABLE 127 JAPAN: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 122
TABLE 128 JAPAN: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 122
9.4.5 REST OF ASIA PACIFIC 123
TABLE 129 REST OF ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 130 REST OF ASIA PACIFIC: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 124
TABLE 131 REST OF ASIA PACIFIC: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 124
TABLE 132 REST OF ASIA PACIFIC: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 124
TABLE 133 REST OF ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 125
TABLE 134 REST OF ASIA PACIFIC: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 135 REST OF ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 126
9.5 REST OF THE WORLD 126
TABLE 136 US VS. MEXICO: AVERAGE COST COMPARISON (USD) 127
9.5.1 ROW: RECESSION IMPACT 127
TABLE 137 REST OF THE WORLD: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 127
TABLE 138 REST OF THE WORLD: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 128
TABLE 139 REST OF THE WORLD: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 128
TABLE 140 REST OF THE WORLD: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 128
TABLE 141 REST OF THE WORLD: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 129
TABLE 142 REST OF THE WORLD: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 143 REST OF THE WORLD: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 130
10 COMPETITIVE LANDSCAPE 131
10.1 OVERVIEW 131
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 131
TABLE 144 OVERVIEW OF STRATEGIES ADOPTED BY KEY BONE CEMENT & GLUE MARKET PLAYERS 131
10.3 MARKET SHARE ANALYSIS, 2022 132
FIGURE 20 BONE CEMENT & GLUE MARKET SHARE ANALYSIS, 2022 132
TABLE 145 BONE CEMENT & GLUE MARKET: DEGREE OF COMPETITION (2022) 132
10.4 REVENUE SHARE ANALYSIS, 2022 133
FIGURE 21 REVENUE ANALYSIS OF TOP FOUR MARKET PLAYERS (USD MILLION) 133
10.5 COMPANY EVALUATION MATRIX, 2022 134
10.5.1 STARS 134
10.5.2 EMERGING LEADERS 134
10.5.3 PERVASIVE PLAYERS 134
10.5.4 PARTICIPANTS 134
FIGURE 22 BONE CEMENT & GLUE MARKET: COMPANY EVALUATION MATRIX (2022) 135
10.6 COMPANY EVALUATION MATRIX FOR SMES/STARTUPS, 2022 135
10.6.1 PROGRESSIVE COMPANIES 135
10.6.2 STARTING BLOCKS 136
10.6.3 RESPONSIVE COMPANIES 136
10.6.4 DYNAMIC COMPANIES 136
FIGURE 23 BONE CEMENT & GLUE MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022) 136
10.7 COMPETITIVE BENCHMARKING 137
TABLE 146 BONE CEMENT & GLUE MARKET: DETAILED LIST OF KEY SMES/STARTUPS 137
10.8 COMPANY FOOTPRINT ANALYSIS 137
TABLE 147 COMPANY FOOTPRINT ANALYSIS 137
TABLE 148 COMPANY PRODUCT FOOTPRINT 138
TABLE 149 COMPANY REGIONAL FOOTPRINT 139
10.9 COMPETITIVE SCENARIO 140
10.9.1 DEALS 140
TABLE 150 DEALS 140
10.9.2 OTHER DEVELOPMENTS 141
TABLE 151 OTHER DEVELOPMENTS 141
11 COMPANY PROFILES 142
11.1 KEY PLAYERS 142
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 STRYKER 142
TABLE 152 STRYKER: BUSINESS OVERVIEW 142
FIGURE 24 STRYKER: COMPANY SNAPSHOT (2022) 143
11.1.2 ZIMMER BIOMET 146
TABLE 153 ZIMMER BIOMET: BUSINESS OVERVIEW 146
FIGURE 25 ZIMMER BIOMET: COMPANY SNAPSHOT (2022) 147
11.1.3 HERAEUS HOLDING 149
TABLE 154 HERAEUS HOLDING: BUSINESS OVERVIEW 149
11.1.4 SMITH+NEPHEW 151
TABLE 155 SMITH+NEPHEW: BUSINESS OVERVIEW 151
FIGURE 26 SMITH & NEPHEW: COMPANY SNAPSHOT (2022) 152
11.1.5 DEPUY SYNTHES (JOHNSON & JOHNSON) 154
TABLE 156 JOHNSON & JOHNSON: BUSINESS OVERVIEW 154
FIGURE 27 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022) 155
11.1.6 ENOVIS 157
TABLE 157 ENOVIS: BUSINESS OVERVIEW 157
FIGURE 28 ENOVIS: COMPANY SNAPSHOT (2022) 157
11.1.7 ARTIVION, INC. 159
TABLE 158 ARTIVION, INC.: BUSINESS OVERVIEW 159
FIGURE 29 ARTIVION, INC.: COMPANY SNAPSHOT (2022) 160
11.1.8 CARDINAL HEALTH 161
TABLE 159 CARDINAL HEALTH: BUSINESS OVERVIEW 161
FIGURE 30 CARDINAL HEALTH.: COMPANY SNAPSHOT (2022) 162
11.1.9 MEDTRONIC 163
TABLE 160 MEDTRONIC: BUSINESS OVERVIEW 163
FIGURE 31 MEDTRONIC: COMPANY SNAPSHOT (2022) 164
11.1.10 GLOBUS MEDICAL 165
TABLE 161 GLOBUS MEDICAL: BUSINESS OVERVIEW 165
FIGURE 32 GLOBUS MEDICAL: COMPANY SNAPSHOT (2022) 166
11.1.11 EXACTECH, INC. 168
TABLE 162 EXACTECH, INC.: BUSINESS OVERVIEW 168
11.1.12 ARTHREX, INC. 169
TABLE 163 ARTHREX, INC.: BUSINESS OVERVIEW 169
11.1.13 TEKNIMED 170
TABLE 164 TEKNIMED: BUSINESS OVERVIEW 170
11.1.14 TECRES S.P.A. 171
TABLE 165 TECRES S.P.A.: BUSINESS OVERVIEW 171
11.1.15 BIOCERAMED S.A. 172
TABLE 166 BIOCERAMED, S.A.: BUSINESS OVERVIEW 172
11.1.16 EVOLUTIS 173
TABLE 167 EVOLUTIS: BUSINESS OVERVIEW 173
11.2 OTHER PLAYERS 174
11.2.1 NORMMED MEDICAL 174
11.2.2 LINACOL MEDICAL INC. 174
11.2.3 BPB MEDICA 175
11.2.4 IZI MEDICAL 175
11.2.5 ADITUS MEDICAL 176
11.2.6 OSARTIS GMBH 176
11.2.7 LD DAVIS 177
11.2.8 MILLIGAN & HIGGINS 177
11.2.9 VHERN S.R.L. 178
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 179
12.1 INDUSTRY INSIGHTS 179
12.2 DISCUSSION GUIDE 180
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 184
12.4 CUSTOMIZATION OPTIONS 186
12.5 RELATED REPORTS 187
12.6 AUTHOR DETAILS 188

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 骨セメント＆接着剤の世界市場予測（～2028）：骨セメント別、骨接着剤別、充填別、用途別、エンドユーザー別、地域別(Bone Cement & Glue Market by Bone Cement (PMMA, Calcium Phosphate), Bone Glue (Natural, Synthetic), Loading (Antibiotic Loaded), Application (Arthroplasty, Kyphoplasty, Vertebroplasty), End User (Hospitals, ASCS, Clinics) & Region - Global Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

骨セメント＆接着剤の世界市場予測（～2028）：骨セメント別、骨接着剤別、充填別、用途別、エンドユーザー別、地域別

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp